PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study - PubMed
Ayhan Ozcan 1 ,
Article ImagesPAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study
Ayhan Ozcan et al. Mod Pathol. 2011 Jun.
Free article
Abstract
PAX 8 is a transcription factor that is essential for embryonic development of the kidney, Müllerian organs, and thyroid. It may also have a role in tumor development in these organs. The diagnostic utility of PAX 8 has not been comprehensively studied. Formalin-fixed, paraffin-embedded tissue samples for non-neoplastic tissues (n=1601), primary neoplasms (n=933), and metastatic neoplasms (n=496) were subjected to PAX 8 immunostain. In non-neoplastic tissues, PAX 8 was consistently noted in glomerular parietal epithelial cells, renal collecting ductal cells, atrophic renal tubular epithelial cells regardless of nephronic segments, and epithelial cells of the endocervix, endometrium, fallopian tube, seminal vesicle, epidydimis, thyroid, pancreatic islet cells, and lymphoid cells. PAX 8 was not seen in the rest of the tissue samples. In primary neoplasms, PAX 8 was expressed by 194 of 240 (89%) renal cell neoplasms, by 238 of 267 (89%) Müllerian-type neoplasms, by 65 of 65 (100%) thyroid follicular cell neoplasms, by 8 of 8 (100%) nephrogenic adenomas, and by 17 of 17 (100%) lymphomas. Weak focal staining was noted in 5 of 12 (42%) cases of parathyroid hyperplasia/adenoma and in 6 of 17 (35%) well-differentiated neuroendocrine tumors of the pancreas. PAX 8 was not seen in other neoplasms. In metastatic neoplasms, PAX 8 was expressed by 90 of 102 (88%) metastatic renal cell carcinomas, by 57 of 63 metastatic Müllerian tumors (90%), and by 6 of 6 metastatic papillary thyroid carcinomas (100%). There was also weak focal staining for 1 of 15 metastatic small cell carcinomas and for 1 of 9 metastatic well-differentiated neuroendocrine carcinomas. PAX 8 was not seen in other metastatic neoplasms. It can be successfully identified in routinely processed tissue samples, and its expression is mostly nuclear. PAX 8 expression in non-neoplastic mature tissues is limited to the organs, the embryonic development of which depends on this transcription factor. This tissue/cell-specific expression is maintained during both neoplastic transformation and metastasis. PAX 8 is a sensitive and specific marker for tumors of renal, Müllerian, or thyroid origin in both primary and metastatic sites.
Similar articles
-
Zhai QJ, Ozcan A, Hamilton C, Shen SS, Coffey D, Krishnan B, Truong LD. Zhai QJ, et al. Appl Immunohistochem Mol Morphol. 2010 Jul;18(4):323-32. doi: 10.1097/PAI.0b013e3181d712ef. Appl Immunohistochem Mol Morphol. 2010. PMID: 20216401
-
Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R. Nonaka D, et al. Mod Pathol. 2008 Feb;21(2):192-200. doi: 10.1038/modpathol.3801002. Epub 2007 Dec 14. Mod Pathol. 2008. PMID: 18084247
-
Ozcan A, Liles N, Coffey D, Shen SS, Truong LD. Ozcan A, et al. Am J Surg Pathol. 2011 Dec;35(12):1837-47. doi: 10.1097/PAS.0b013e31822d787c. Am J Surg Pathol. 2011. PMID: 21989345
-
Value of PAX 8 immunostaining in tumor diagnosis: a review and update.
Ordóñez NG. Ordóñez NG. Adv Anat Pathol. 2012 May;19(3):140-51. doi: 10.1097/PAP.0b013e318253465d. Adv Anat Pathol. 2012. PMID: 22498579 Review.
Cited by
-
Gorbokon N, Baltruschat S, Lennartz M, Luebke AM, Höflmayer D, Kluth M, Hube-Magg C, Hinsch A, Fraune C, Lebok P, Bernreuther C, Sauter G, Marx AH, Simon R, Krech T, Clauditz TS, Jacobsen F, Burandt E, Steurer S, Minner S. Gorbokon N, et al. Virchows Arch. 2024 Sep;485(3):491-507. doi: 10.1007/s00428-024-03872-y. Epub 2024 Aug 6. Virchows Arch. 2024. PMID: 39105782 Free PMC article.
-
Guo J, Lv X, Zhang W, Dong F, Li L, Liu J, Li B. Guo J, et al. Front Oncol. 2024 Apr 9;14:1359985. doi: 10.3389/fonc.2024.1359985. eCollection 2024. Front Oncol. 2024. PMID: 38655141 Free PMC article.
-
Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA.
Hoshino H, Inoue D, Shinagawa A, Yoshida H, Shigeto S, Matsuda K, Akama TO, Yoshida Y, Kobayashi M. Hoshino H, et al. Hum Cell. 2024 Jul;37(4):1184-1193. doi: 10.1007/s13577-024-01058-x. Epub 2024 Apr 4. Hum Cell. 2024. PMID: 38573494 Free PMC article.
-
Liu S, Yan Y, Cui Z, Feng H, Zhong F, Liu Z, Li Y, Ou X, Li W. Liu S, et al. BMC Cancer. 2023 Nov 27;23(1):1149. doi: 10.1186/s12885-023-11651-2. BMC Cancer. 2023. PMID: 38012622 Free PMC article.
-
Thyroid hormone receptor α1: a novel regulator of thyroid cancer cell differentiation.
Hwang E, Doolittle WKL, Zhu YJ, Zhu X, Zhao L, Yu Y, Cheng SY. Hwang E, et al. Oncogene. 2023 Oct;42(41):3075-3086. doi: 10.1038/s41388-023-02815-2. Epub 2023 Aug 26. Oncogene. 2023. PMID: 37634007
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases